Ireland will host BioPharma Ambition® 2020

Ireland will host BioPharma Ambition® 2020

The island of Ireland has established itself as a place of global significance for the biopharmaceutical industry and is set to capitalise on this and host a major international multi-function convention in Dublin on the 3rd-4th of March 2020.

The Irish Pharmaceutical Healthcare Association and BioPharmaChem Ireland, representing the research based and manufacturing biopharmaceutical industries respectively, together with the National Institute for BioProcessing Research and Training will host BioPharma Ambition®, a multi-platform event to inspire and showcase innovation.

With international policy leaders, renowned researchers and senior industry personnel, the event will highlight the ambition of the industry for the health and well-being of populations. It will also highlight where the research is pointing and how Ireland will support innovation in discovery, development, manufacturing and healthcare solutions.

Conference Sessions Include:

  • Manufacturing Next-Generation Biologics
  • Partnerships for Unlocking the Value of Innovation
  • Connected Health
  • Factory 4.0: The New Manufacturing Sites
  • Future-Fitting Biopharma for Best Societal Impact

Speakers Include:

  • Jim O’Donoghue, President, S3 Connected Health
  • Dr Lorraine Nolan, Chief Executive, Health Products Regulatory Authority
  • Hannes Toivane, Lead for Strategic Partnerships, Centre of Excellence for Innovation Nordics, Takeda
  • Joe Keenan, Global Digital Health Solutions Director, Novartis
  • Arup Roy, Vice President, Bioproduct Research and Development, Eli Lilly
  • Joan Byrne, Vice President, Science and Technology, Drug and Device, AbbVie
  • James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)
  • Dominic Carolan, CEO, NIBRT


For more information